BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26976106)

  • 1. A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein.
    Massignan T; Cimini S; Stincardini C; Cerovic M; Vanni I; Elezgarai SR; Moreno J; Stravalaci M; Negro A; Sangiovanni V; Restelli E; Riccardi G; Gobbi M; Castilla J; Borsello T; Nonno R; Biasini E
    Sci Rep; 2016 Mar; 6():23180. PubMed ID: 26976106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of Peptide Aptamers with Prion Protein Central Domain Promotes α-Cleavage of PrP
    Corda E; Du X; Shim SY; Klein AN; Siltberg-Liberles J; Gilch S
    Mol Neurobiol; 2018 Oct; 55(10):7758-7774. PubMed ID: 29460268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion.
    Hara H; Sakaguchi S
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Compound That Disrupts Binding of Amyloid-β to the Prion Protein Using a Novel Fluorescence-based Assay.
    Risse E; Nicoll AJ; Taylor WA; Wright D; Badoni M; Yang X; Farrow MA; Collinge J
    J Biol Chem; 2015 Jul; 290(27):17020-8. PubMed ID: 25995455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication.
    Resenberger UK; Harmeier A; Woerner AC; Goodman JL; Müller V; Krishnan R; Vabulas RM; Kretzschmar HA; Lindquist S; Hartl FU; Multhaup G; Winklhofer KF; Tatzelt J
    EMBO J; 2011 May; 30(10):2057-70. PubMed ID: 21441896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5).
    Haas LT; Kostylev MA; Strittmatter SM
    J Biol Chem; 2014 Oct; 289(41):28460-77. PubMed ID: 25148681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human prion protein inhibits prion propagation in vitro.
    Yuan J; Zhan YA; Abskharon R; Xiao X; Martinez MC; Zhou X; Kneale G; Mikol J; Lehmann S; Surewicz WK; Castilla J; Steyaert J; Zhang S; Kong Q; Petersen RB; Wohlkonig A; Zou WQ
    Sci Rep; 2013 Oct; 3():2911. PubMed ID: 24105336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the inhibition of α-synuclein oligomerization by a pharmacological chaperone that prevents prion formation by the protein PrP.
    Dong C; Garen CR; Mercier P; Petersen NO; Woodside MT
    Protein Sci; 2019 Sep; 28(9):1690-1702. PubMed ID: 31306510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion protein self-peptides modulate prion interactions and conversion.
    Rigter A; Priem J; Timmers-Parohi D; Langeveld JP; van Zijderveld FG; Bossers A
    BMC Biochem; 2009 Nov; 10():29. PubMed ID: 19943977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextran sulfate sodium inhibits amyloid-β oligomer binding to cellular prion protein.
    Aimi T; Suzuki K; Hoshino T; Mizushima T
    J Neurochem; 2015 Aug; 134(4):611-7. PubMed ID: 25963375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Aβ aggregates can inhibit prion propagation.
    Sarell CJ; Quarterman E; Yip DC; Terry C; Nicoll AJ; Wadsworth JDF; Farrow MA; Walsh DM; Collinge J
    Open Biol; 2017 Nov; 7(11):. PubMed ID: 29142106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The compound (3-{5-[(2,5-dimethoxyphenyl)amino]-1,3,4-thiadiazolidin-2-yl}-5,8-methoxy-2H-chromen-2-one) inhibits the prion protein conversion from PrP
    Pagadala NS; Bjorndahl TC; Joyce M; Wishart DS; Syed K; Landi A
    Bioorg Med Chem; 2017 Oct; 25(20):5875-5888. PubMed ID: 28951092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Alkaline Phosphatase-Fused Mouse Prion Protein and Its Application in Toxic Aβ Oligomer Detection.
    Tsukakoshi K; Kubo R; Ikebukuro K
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Promising Antiprion Trimethoxychalcone Binds to the Globular Domain of the Cellular Prion Protein and Changes Its Cellular Location.
    Ferreira NC; Ascari LM; Hughson AG; Cavalheiro GR; Góes CF; Fernandes PN; Hollister JR; da Conceição RA; Silva DS; Souza AMT; Barbosa MLC; Lara FA; Martins RAP; Caughey B; Cordeiro Y
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.
    Um JW; Nygaard HB; Heiss JK; Kostylev MA; Stagi M; Vortmeyer A; Wisniewski T; Gunther EC; Strittmatter SM
    Nat Neurosci; 2012 Sep; 15(9):1227-35. PubMed ID: 22820466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion protein facilitates retinal iron uptake and is cleaved at the β-site: Implications for retinal iron homeostasis in prion disorders.
    Asthana A; Baksi S; Ashok A; Karmakar S; Mammadova N; Kokemuller R; Greenlee MH; Kong Q; Singh N
    Sci Rep; 2017 Aug; 7(1):9600. PubMed ID: 28851903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-prion RNA aptamer R12 disrupts the Alzheimer's disease-related complex between prion and amyloid β.
    Iida M; Mashima T; Yamaoki Y; So M; Nagata T; Katahira M
    FEBS J; 2019 Jun; 286(12):2355-2365. PubMed ID: 30916478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.